Compare VSME & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VSME | EVGN |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | | Agricultural Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 9.0M |
| IPO Year | 2023 | N/A |
| Metric | VSME | EVGN |
|---|---|---|
| Price | $0.08 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 11.3M | 44.7K |
| Earning Date | 04-14-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,483,152.00 | ★ $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $0.07 | $0.95 |
| 52 Week High | $3.21 | $2.42 |
| Indicator | VSME | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 25.16 | 44.43 |
| Support Level | $0.07 | $0.96 |
| Resistance Level | $0.12 | $1.06 |
| Average True Range (ATR) | 0.01 | 0.05 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 16.52 | 39.10 |
VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.